Charge Heterogeneity Analysis of Rituximab Innovator and Biosimilar mAbs
Applications | 2017 | Agilent TechnologiesInstrumentation
Consumables, HPLC, LC columns
IndustriesPharma & Biopharma
ManufacturerAgilent Technologies
Key wordsinnovator, biosimilar, rituximab, variant, variants, ristova, charge, reditux, mau, cpb, basic, profiles, acidic, mabs, min, carboxypeptidase, main, mobile, bio, mab, phase, mean, area, peak, separation, rsd, digestion, advisor, tcc, iex, untreated, heterogeneity, correspond, exchange, peek, agilent, antibodies, quaternary, monoclonal, treated, gradient, percent, salt, peaks, confirmed, after, disappearance, buffer, parameters, treatment
Similar PDF
Agilent Biocolumns - Charge Variant Analysis - Application Compendium
2021|Agilent Technologies|Guides
Agilent Biocolumns Charge Variant Analysis Application Compendium Contents Background 2 Getting Started 3 How to Guide - Ion-Exchange Chromatography for Biomolecule Analysis - 5991-3775EN 4 Featured Application Notes 22 Convenient Customization of Your Cation Exchange Analysis 5994-3257EN 22 How…
Key words
return, returnsection, sectioncontents, contentsbuffer, buffercharge, chargeexchange, exchangevariants, variantsvariant, variantadvisor, advisorgradient, gradientmau, maugradients, gradientsmin, minmobile, mobilecex
Monoclonal Antibody Charge Heterogeneity Analysis by CZE and CZE/MS
2016|Agilent Technologies|Applications
Monoclonal Antibody Charge Heterogeneity Analysis by CZE and CZE/MS Comparison of charge variant profiles of Rituximab Innovator and Biosimilar mAbs Application Note Biopharmaceutical Author Introduction Suresh Babu C.V. During biosysnthesis, various post-translational modifications (PTMs) will lead to charge heterogeneity in…
Key words
biosimilar, biosimilarinnovator, innovatorvariants, variantsbasic, basiccharge, chargerituximab, rituximabcze, czeprofiles, profilesacidic, acidicristova, ristovareditux, redituxmain, mainmass, massdeconvoluted, deconvolutedmean
Charge Variant and Aggregation Analysis of Innovator and Biosimilars of Rituximab
2019|Agilent Technologies|Applications
Application Note Pharma & Biopharma Charge Variant and Aggregation Analysis of Innovator and Biosimilars of Rituximab Author Bian Yulan Global Solution Development Center, Global Laboratory Solution Sales (LSS) Marketing, Agilent Technologies Singapore (Sales) Pte. Ltd. Abstract Monoclonal antibodies are an…
Key words
innovator, innovatorvariants, variantsbiosimilars, biosimilarsrituximab, rituximabrsd, rsdhmws, hmwsarea, areabasic, basiclmws, lmwsmain, mainmau, maumab, mabcharge, chargeacidic, acidicpeak
Seamless Method Transfer from an Agilent 1260 Infinity Bio-inert LC to an Agilent 1260 Infinity II Bio-inert LC
2016|Agilent Technologies|Applications
Seamless Method Transfer from an Agilent 1260 Infinity Bio-inert LC to an Agilent 1260 Infinity II Bio-inert LC Charge Variant Analysis of Rituximab Innovator and Biosimilar Application Note Biologics & Biosimilars Author Abstract Sonja Schneider Monitoring the charge heterogeneity of…
Key words
biosimilar, biosimilarinnovator, innovatorbio, bioinert, inertrituximab, rituximabcharge, chargevariants, variantsadvisor, advisormau, mauvariant, variantbuffer, buffermin, minsystem, systemscouting, scoutinglymphoma